BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7195986)

  • 1. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa.
    Whittle BJ; Kauffman GL; Moncada S
    Nature; 1981 Jul; 292(5822):472-4. PubMed ID: 7195986
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
    Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
    Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
    Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives.
    Roth DM; Lefer AM; Smith JB; Nicolaou KC
    Prostaglandins Leukot Med; 1982 Nov; 9(5):503-9. PubMed ID: 6960376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
    [No Abstract]   [Full Text] [Related]  

  • 7. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tripeptide ZAMI-420 inhibits thromboxane-induced gastric vasoconstriction and ischaemia.
    Moroni D; Gervasi GB; Patella P; Visentin L; Maselli MA; Bergamaschi M
    Int J Tissue React; 1983; 5(3):249-52. PubMed ID: 6654624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-immersion stress induces mucosal ischemia due to thromboxane A2-like substance and ulcer formation in rats.
    Kitagawa H; Kurahashi K; Fujiwara M
    Jpn J Pharmacol; 1984 Aug; 35(4):478-80. PubMed ID: 6542156
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of thromboxane synthetase inhibitors.
    Smith JB
    Fed Proc; 1987 Jan; 46(1):139-43. PubMed ID: 3542573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
    Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
    Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 14. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR; Fitzpatrick FA; Miller OV
    Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of experimentally induced gastric damage with the tripeptide ZAMI-420, a new thromboxane synthesis inhibitor.
    Gervasi GB; Fossati A; Caliari S; Rapalli L; Bergamaschi M
    Int J Tissue React; 1983; 5(3):253-6. PubMed ID: 6418678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 17. Membrane protein mediation of thromboxane A2-induced platelet aggregation.
    Kao KJ; Hagen PO; Pizzo SV
    Biochem Biophys Res Commun; 1980 Nov; 97(1):87-93. PubMed ID: 6779820
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial ischemia in dogs.
    Burke SE; Antonaccio MJ; Lefer AM
    Basic Res Cardiol; 1982; 77(4):411-22. PubMed ID: 6890805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
    Vargaftig BB; Fouque F; Joseph D; Odiot J; Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():429-33. PubMed ID: 6221558
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the vascular responses to various prostanoic compounds in the puppy and adult dog.
    Fitzpatrick T; Harris R; Ramwell P; Kot P
    Adv Prostaglandin Thromboxane Res; 1980; 7():727-9. PubMed ID: 6989200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.